Expression and cell distribution of group I and group II metabotropic glutamate receptor subtypes in Taylor-type focal cortical dysplasia

Epilepsia

Volumn 44, Issue 6, 2003, Pages 785-795

  Aronica, Eleonora ^a,b,f   Gorter, Jan A ^b,c   Jansen, Gerard H ^d   Van Veelen, Cees W M ^e   Van Rijen, Peter C ^e   Ramkema, Marja ^a   Troost, Dirk ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY OF OTTAWA   (Canada)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Balloon cells; Epilepsy; Focal cortical dysplasia; Immunocytochemistry; Metabotropic glutamate receptors

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; METABOTROPIC RECEPTOR; MICROTUBULE ASSOCIATED PROTEIN 2; RECEPTOR SUBTYPE;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTE; BALLOON CELL; CELL NUCLEUS; CELL SUBPOPULATION; CELL TYPE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL DYSPLASIA; EPILEPSY; EPILEPTOGENESIS; FEMALE; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; NERVE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADOLESCENT; ADULT; ASTROCYTES; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; NERVOUS SYSTEM MALFORMATIONS; NEURONS; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 0037630058     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2003.54802.x     Document Type: Article

References (81)

1. Mischel PS, Nguyen LP, Vinters HV. Cerebral cortical dysplasia associated with pediatric epilepsy: review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 1995;54:137-53.
2. Crino PB, Miyata H, Vinters HV. Neurodevelopmental disorders as a cause of seizures: neuropathologic, genetic, and mechanistic considerations. Brain Pathol 2002;12:212-33.
3. Taylor DC, Falconer MA, Bruton CJ, et al. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 1971;34:369-87.
4. Vinters HV, Fisher RS, Cornford ME, et al. Morphological substrates of infantile spasms: studies based on surgically resected cerebral tissue. Childs Nerv Sysr 1992;8:8-17.
5. Palmini A, Gambardella A, Andermann F, et al. Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Ann Neurol 1995;37:476-87.
6. Mattia D, Olivier A, Avoli M. Seizure-like discharges recorded in human dysplastic neocortex maintained in vitro. Neurology 1995;45:1391-5.
7. Jacobs KM, Kharazia VN, Prince DA. Mechanisms underlying epileptogenesis in cortical malformations. Epilepsy Res 1999; 36:165-88.
8. Avoli M, Mattia D, Olivier A. A window on the physiopathogenesis of seizures in patients with cortical dysplasia. Adv Exp Med Biol 2002;497:123-32.
9. Swann JW, Hablitz JJ. Cellular abnormalities and synaptic plasticity in seizure disorders of the immature nervous system. Ment Retard Dev Disabil Res Rev 2000;6:258-67.
10. Jacobs KM, Gutnick MJ, Prince DA. Hyperexcitability in a model of cortical maldevelopment. Cereb Cortex 1996;6:514-23.
11. Najm IM, Ying Z, Babb T, et al. Epileptogenicity correlated with increased N-methyl-D-aspartate receptor subunit NR2A/B in human focal cortical dysplasia. Epilepsia 2000;41:971-6.
12. DeFazio RA, Hablitz JJ. Alterations in NMDA receptors in a rat model of cortical dysplasia. J Neurophysiol 2000;83:315-21.
13. Ying Z, Babb TL, Comair YG, et al. Induced expression of NMDAR2 proteins and differential expression of NMDAR1 splice variants in dysplastic neurons of human epileptic neocortex. J Neuropathol Exp Neurol 1998;57:47-62.
14. Avoli M, Bernasconi A, Mattia D, et al. Epileptiform discharges in the human dysplastic neocortex: in vitro physiology and pharmacology. Ann Neurol 1999;46:816-26.
15. Hablitz JJ, DeFazio RA. Altered receptor subunit expression in rat neocortical malformations. Epilepsia 2000;41:S82-5.
16. Crino PB, Duhaime AC, Baltuch G, et al. Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia. Neurology 2001;56:906-13.
17. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science 1992;258:597-603.
18. Pin JP, Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 1995;34:1-26.
19. Schoepp DD, Jane DE, Monn JA. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 1999;38:1431-76.
20. Wong RK, Bianchi R, Taylor GW, et al. Role of metabotropic glutamate receptors in epilepsy. Adv Neurol 1999;79:685-98.
21. Chapman AG. Glutamate receptors in epilepsy. Prog Brain Res 1998;116:371-83.
22. Tizzano JP, Griffey KI, Schoepp DD. Induction or protection of limbic seizures in mice by mGluR subtype selective agonists. Neuropharmacology 1995;34:1063-7.
23. Burke JP, Hablitz JJ. Modulation of epileptiform activity by metabotropic glutamate receptors in immature rat neocortex. J Neurophysiol 1995;73:205-17.
24. Chapman AG, Nanan K, Williams M, et al. Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893). Neuropharmacology 2000;39:1567-74.
25. Greenwood RS, Fan Z, McHugh R, et al. Inhibition of hippocampal kindling by metabotropic glutamate receptor antisense oligonucleotides. Mol Cell Neurosci 2000;16:233-43.
26. Folbergrova J, Haugvicova R, Mares P. Attenuation of seizures induced by homocysteic acid in immature rats by metabotropic glutamate group II and group III receptor agonists. Brain Res 2001;908:120-9.
27. Moldrich RX, Beart PM, Jane DE, et al. Anticonvulsant activity of 3,4-dicarboxyphenylglycines in DBA/2 mice. Neuropharmacology 2001;40:732-5.
28. Moldrich RX, Jeffrey M, Talebi A, et al. Anti-epileptic activity of group II metabotropic glutamate receptor agonists (-)-2oxa-4-aminobicyclo(3.1.0)hexane-4,6-dicarboxylate (LY379268) and (-)-2-thia-4-aminobicyclo(3.1.0)hexane-4,6-dicarboxylate (LY389795). Neuropharmacology 2001;41:8-18.
29. Merlin LR. Differential roles for mGluR1 and mGluR5 in the persistent prolongation of epileptiform bursts. J Neurophysiol 2002;87:621-5.
30. van Veelen CW, Debets RM, van Huffelen AC, et al. Combined use of subdural and intracerebral electrodes in preoperative evaluation of epilepsy. Neurosurgery 1990;26:93-101.
31. Engel JJ. Outcome with respect to epileptic seizures. In: Engel JE Jr. ed. Surgical treatment of epilepsy. New York: Raven Press, 1987:553-71.
32. Aronica E, Catania MV, Geurts J, et al. Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes. Neuroscience 2001;105:509-20.
33. Aronica E, Yankaya B, Jansen GH, et al. Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy. Neuropathol Appl Neurobiol 2001;27:223-37.
34. Romijn HJ, Uum JF, Breedijk I, et al. Double immunolabeling of neuropeptides in the human hypothalamus as analyzed by confocal laser scanning fluorescence microscopy. J Histochem Cytochem 1999;47:229-36.
35. Khurgel M, Ivy GO. Astrocytes in kindling: relevance to epileptogenesis. Epilepsy Res 1996;26:163-75.
36. Aronica E, van Vliet EA, Mayboroda OA, et al. Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy. Eur J Neurosci 2000;12:2333-44.
37. Tassi L, Colombo N, Garbelli, R, et al. Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 2002;125:1719-32.
38. Ong WY, He Y, Tan KK, et al. Differential localisation of the metabotropic glutamate receptor mGluR1a and the ionotropic glutamate receptor GluR2/3 in neurons of the human cerebral cortex. Exp Brain Res 1998;119:367-74.
39. Oka A, Takashima S. The up-regulation of metabotropic glutamate receptor 5 (mGluR5) in Down's syndrome brains. Acta Neuropathol (Berl) 1999;97:275-8.
40. Tang FR, Lee WL, Yeo TT. Expression of the group I metabotropic glutamate receptor in the hippocampus of patients with mesial temporal lobe epilepsy. J Neurocytol 2001;30:403-11.
41. Tang FR, Lee WL. Expression of the group II and III metabotropic glutamate receptors in the hippocampus of patients with mesial temporal lobe epilepsy. J Neurocytol 2001;30:137-43.
42. Phillips T, Rees S, Augood S, et al. Localization of metabotropic glutamate receptor type 2 in the human brain. Neuroscience 2000;95:1139-56.
43. Mizoguchi M, Iwaki T, Morioka T, et al. Abnormal cytoarchitecture of cortical dysplasia verified by immunohistochemistry. Clin Neuropathol 1998;17:10-9.
44. Babb TL, Ying Z, Hadam J, et al. Glutamate receptor mechanisms in human epileptic dysplastic cortex. Epilepsy Res 1998;32:24-33.
45. Spreafico R, Battaglia G, Arcelli P, et al. Cortical dysplasia: an immunocytochemical study of three patients. Neurology 1998;50:27-36.
46. Hilbig A, Babb TL, Najm I, et al. Focal cortical dysplasia in children. Dev Neurosci 1999;21:271-80.
47. Merlin LR. Metabotropic glutamate receptors in the plasticity of excitatory responses in the hippocampus: clinical impact. Adv Exp Med Biol 1998;446:131-44.
48. Merlin LR, Wong RK. Role of group I metabotropic glutamate receptors in the patterning of epileptiform activities in vitro. J Neurophysiol 1997;78:539-44.
49. Merlin LR. Group I mGluR-mediated silent induction of long-lasting epileptiform discharges. J Neurophysiol 1999;82:1078-81.
50. Takahashi H, Wakabayashi K, Kawai K, et al. Neuroendocrine markers in central nervous system neuronal tumors (gangliocytoma and ganglioglioma). Acta Neuropathol 1989;77:237-43.
51. Jay V, Becker LE, Otsubo H, Hwang PA, et al. Pathology of temporal lobectomy for refractory seizures in children: review of 20 cases including some unique malformative lesions. J Neurosurg 1993;79:53-61.
52. Prayson RA, Estes ML, Morris HH. Coexistence of neoplasia and cortical dysplasia in patients presenting with seizures. Epilepsia 1993;34:609-15.
53. Zhu JJ, Leon SP, Folkerth RD, et al. Evidence for clonal origin of neoplastic neuronal and gliall cells in gangliogliomas. Am J Pathol 1997;151:565-71.
54. Blumcke I, Wiestler OD. Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol 2002;61:575-84.
55. Akbar MT, Rattray M, Powell JF, et al. Altered expression of group I metabotropic glutamate receptors in the hippocampus of amygdalakindled rats. Brain Res Mol Brain Res 1996;43:105-16.
56. Aronica EM, Gorter JA, Paupard MC, et al. Status epilepticus-induced alterations in metabotropic glutamate receptor expression in young and adult rats. J Neurosci 1997;17:8588-95.
57. Blumcke I, Becker AJ, Klein C, et al. Temporal lobe epilepsy associated up-regulation of metabotropic glutamate receptors: correlated changes in mGluR 1 mRNA and protein expression in experimental animals and human patients. J Neuropathol Exp Neurol 2000;59:1-10.
58. Dietrich D, Kral T, Clusmann H, et al. Reduced function of L-AP4-sensitive metabotropic glutamate receptors in human epileptic sclerotic hippocampus. Eur J Neurosci 1999;11:1109-13.
59. Neugebauer V, Keele NB, Shinnick-Gallagher P. Epileptogenesis in vivo enhances the sensitivity of inhibitory presynaptic metabotropic glutamate receptors in basolateral amygdala neurons in vitro. J Neurosci 1997;17:983-95.
60. Tang E, Yip PK, Chapman AG, et al. Prolonged anticonvulsant action of glutamate metabotropic receptor agonists in inferior colliculus of genetically epilepsy-prone rats. Eur J Pharmacol 1997;327:109-15.
61. Attwell PJ, Koumentaki A, Abdul-Ghani AS, et al. Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats. Brain Res 1998;787:286-91.
62. Keele NB, Neugebauer V, Shinnick-Gallagher P. Differential effects of metabotropic glutamate receptor antagonists on bursting activity in the amygdala. J Neurophysiol 1999;81:2056-65.
63. Anneser JM, Horstmann S, Weydt P, et al. Activation of metabotropic glutamate receptors delays apoptosis of chick embryonic motor neurons in vitro. Neuroreport 1998;9:2039-43.
64. Copani A, Bruno V, Battaglia G, et al. Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide. Mol Pharmacol 1995;47: 890-7.
65. Rosenow F, Luders HO, Dinner DS, et al. Histopathological correlates of epileptogenicity as expressed by electrocorticographic spiking and seizure frequency. Epilepsia 1998;39:850-6.
66. Farrell MA, DeRosa MJ, Curran JG, et al. Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy. Acta Neuropathol 1992;83:246-59.
67. Wolf HK, Birkholz T, Wellmer J, et al. Neurochemical profile of glioneuronal lesions from patients with pharmacoresistant focal epilepsies. J Neuropathol Exp Neurol 1995;54:689-97.
68. Miller S, Kesslak JP, Romano C, et al. Roles of metabotropic glutamate receptors in brain plasticity and pathology. Ann N Y Acad Sci 1995;757:460-74.
69. Romano C, Sesma MCTM, O'alley K, et al. Distribution of metabotropic glutamate receptor mGluR immunoreactivity in rat brain. J Comp Neurol 1995;355:455-69.
70. Ulas J, Satou T, Ivins KJ, et al. Expression of metabotropic glutamate receptor 5 is increased in astrocytes after kainate-induced epileptic seizures. Glia 2000;30:352-61.
71. Ferraguti F, Corti C, Valerio E, et al. Activated astrocytes in areas of kainate-induced neuronal injury upregulate the expression of the metabotropic glutamate receptors 2/3 and 5. Exp Brain Res 2001;137:1-11.
72. Winder DG, Ritch PS, Gereau RW IV, et al. Novel glial-neuronal signalling by coactivation of metabotropic glutamate and beta-adrenergic receptors in rat hippocampus. J Physiol (Lond) 1996;494:743-55.
73. Carmignoto G. Central role of neuron-to-astrocyte signalling in the control of brain microcirculation. Neuropharmacology 2002:43:180.
74. Bruno V, Battaglia G, Casabona G, et al. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J Neurosci 1998;18:9594-600.
75. Ciccarelli R, Di Iorio P, Bruno V, et al. Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes. Glia 1999;27:275-81.
76. Lee SH, Magge S, Spencer DD, et al. Human epileptic astrocytes exhibit increased gap junction coupling. Glia 1995;15:195-202.
77. Attwell D. Glia and neurons in dialogue [news; comment]. Nature 1994;369:707-8.
78. Parpura V, Basarsky TA, Liu F, et al. Glutamate-mediated astrocyte-neuron signalling [see comments]. Nature 1994;369:744-7.
79. Ciccarelli R, Sureda FX, Casabona G, et al. Opposite influence of the metabotropic glutamate receptor subtypes mGlu3 and -5 on astrocyte proliferation in culture. Glia 1997;21:390-8.
80. Gegelashvili G, Dehnes Y, Danbolt NC, et al. The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms. Neurochem Int 2000;37:163-70.
81. Aronica E, Gorter JA, Ijlst-Keizers H, et al. Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. European Journal of Neuroscience (in press).